Fundraising Fox
/Companies
Sign in

Nference

Cambridge, US · 2 known investors

Find your way into Nference

Sign up to see every warm intro you have to Nference

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nference team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

nference transforms unstructured biomedical data from electronic medical records into technological solutions that enable scientific discovery of diagnostics and treatments. The company partners with medical centers to synthesize healthcare data for personalized medicine research.

AI & Machine LearningBiotechData & InfrastructureDigital Health

Founders & leadership

VS
Venkataramanan SoundararajanCo-founder
ARAjit Rajasekharan
Ajit RajasekharanCo-founder · CTO
MAMurali Aravamudan
Murali AravamudanFounder
VSVenky Soundararajan
Venky SoundararajanFounderChief Scientific Officer at nference, which develops biomedical AI software for extracting insights from electronic medical records to support clinical research and precision medicine. Soundararajan has founded or led multiple affiliated ventures including Anumana, Pramana, and Vimana, working on diagnostics, medical devices, and therapeutics.
TM
Thomas McNaughtonNamed on SEC filing
JH
John HalamkaNamed on SEC filing

Board

DG
David GoelBoard director

Investors · 2

NTT Venture Capitallisted by NTT Venture CapitalMenlo Park

How we know: NTT Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$12.3M disclosed across 2 rounds · 2020–2022

▶$2.7MraisedNov 2022 · 72 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas McNaughtonExecutive Officer
  • Venkataramanan SoundararajanExecutive Officer
  • Murali AravamudanExecutive Officer, Director
  • John HalamkaDirector
  • David GoelDirector
  • Ajit RajasekharanExecutive Officer
Offering amount
$2.7M
Amount sold
$2.7M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.6MraisedMar 2020 · 57 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Murali AravamudanExecutive Officer, Director
  • Venkataramanan SoundararajanExecutive Officer
  • Harris FishmanExecutive Officer
  • Agustin MarquezExecutive Officer
  • Andrew DanielsenDirector
  • David GoelDirector
  • Ajit RajasekharanExecutive Officer
  • Tim BarrowsDirector
Offering amount
$9.6M
Amount sold
$9.6M
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Nference went on to found or lead other companies.

Mark KalinichLead Clinical ScientistFounded Watershed Informatics Inc.Venky SoundararajanFounderFounded Anumana

Frequently asked questions

What does Nference do?
nference transforms unstructured biomedical data from electronic medical records into technological solutions that enable scientific discovery of diagnostics and treatments. The company partners with medical centers to synthesize healthcare data for personalized medicine research.
Who founded Nference?
Nference was founded by Venkataramanan Soundararajan, Ajit Rajasekharan, Murali Aravamudan, Venky Soundararajan.
Who are Nference's investors?
Nference's investors include Matrix, NTT Venture Capital.
How much funding has Nference raised?
Nference has disclosed $12.3M raised across 2 rounds.
Where is Nference headquartered?
Nference is headquartered in Cambridge, US.